ClinicalTrialsFinder

BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 Clinical Trials in Washington D.C., District of Columbia

1 recruitingWashington D.C., District of Columbia

Showing 1–1 of 1 trials

Recruiting
Phase 2

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Metastatic Castrate Resistant Prostate CancerBARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2RAD51B, RAD51C, RAD51D, or RAD54L Mutations
VA Office of Research and Development100 enrolled18 locationsNCT04038502